Diabetic Medicine

Announcement
pp. i-ii(1)

Does one size really fit all? Only by considering individual preferences and priorities will the true impact of insulin pump therapy on quality of life be determined
pp. 693-695(3)
Authors: Speight, J.; Shaw, J. A. M.

A new era in finding Type 2 diabetes genes—the unusual suspects: RD Lawrence Lecture 2006
pp. 696-701(6)
Author: Frayling, T. M.

A −243A→G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects
pp. 702-706(5)
Authors: Boesgaard, T. W.; Castella, S. I.; Andersen, G.; Albrechtsen, A.; Sparsø, T.; Borch-Johnsen, K.; Jørgensen, T.; Hansen, T.; Pedersen, O.

The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities
pp. 707-713(7)
Authors: Rica, I.; Luzuriaga, C.; Pérez de Nanclares, G.; Estalella, I.; Aragonés, A.; Barrio, R.; Bilbao, J. R.; Carlés, C.; Fernández, C.; Fernández, J. M.; Fernández-Rebollo, E.; Gastaldo, E.; Giralt, P; Gomez Vida, J. M.; Gutiérrez, A.; López Siguero, J. P.; Martínez-Aedo, M. J.; Muñoz, M.; Prieto, J.; Rodrigo, J.; Vargas, F.; Castano, L.

A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin
pp. 714-719(6)
Authors: Davies, M. J.; Thaware, P. K.; Tringham, J. R.; Howe, J.; Jarvis, J.; Johnston, V.; Kitchener, D. L.; Skinner, T. C.; McNally, P. G.; Lawrence, I. G.

Caffeine restores regional brain activation in acute hypoglycaemia in healthy volunteers
pp. 720-727(8)
Authors: Rosenthal, M. J.; Smith, D.; Yaguez, L.; Giampietro, V.; Kerr, D.; Bullmore, E.; Brammer, M.; Williams, S. C. R.; Amiel, S. A.

Body composition in young female adults with Type 1 diabetes mellitus. A prospective case-control study
pp. 728-734(7)
Authors: Särnblad, S.; Ingberg, C.M.; Åman, J.; Schvarcz, E.

No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: a cross-sectional study
pp. 735-740(6)
Authors: Wessels, A. M.; Pouwer, F.; Geelhoed-Duijvestijn, P. H. L. M.; Snel, M.; Kostense, P. J.; Scheltens, P.; Heine, R. J.; Snoek, F.J.

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus
pp. 741-746(6)
Authors: Tong, P. C. Y.; Kong, A. P.; So, W Y.; Yang, X.; Ng, M C. Y.; Ho, C S.; Ma, R C. W.; Ozaki, R.; Ng, V.; Chow, C C.; Lam, C W. K.; Chan, J C. N.; Cockram, C S.

Foot abnormalities in Canadian Aboriginal adolescents with Type 2 diabetes
pp. 747-752(6)
Authors: Chuback, J.; Embil, J. M.; Sellers, E.; Trepman, E.; Cheang, M.; Dean, H.

A method for assessing quality of control from glucose profiles
pp. 753-758(6)
Authors: Hill, N. R.; Hindmarsh, P. C.; Stevens, R. J.; Stratton, I. M.; Levy, J. C.; Matthews, D. R.

Differential effect of β-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
pp. 759-763(5)
Authors: Fonseca, V.; Bakris, G. L.; Bell, D. S. H.; McGill, J. B.; Raskin, P.; Messerli, F. H.; Phillips, R. A.; Katholi, R. E.; Wright, J. T.; Waterhouse, B.; Lukas, M. A.; Anderson, K. M.

A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years
pp. 764-769(6)
Authors: Holmes-Walker, D. J.; Llewellyn, A. C.; Farrell, K.

Development of an educational `toolkit' for health professionals and their patients with prediabetes: The WAKEUP study (Ways of Addressing Knowledge Education and Understanding in Pre-diabetes)
pp. 770-777(8)
Authors: Evans, P. H.; Greaves, C.; Winder, R.; Fearn-Smith, J.; Campbell, J. L.

A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone
pp. 778-783(6)
Authors: Thomas, R. M.; Aldibbiat, A.; Griffin, W.; Cox, M. A. A.; Leech, N. J.; Shaw, J. A. M.

Reduced peripheral blood mitochondrial DNA content is not a risk factor for Type 2 diabetes
pp. 784-787(4)
Authors: Singh, R.; Hattersley, A. T.; Harries, L. W.

Glucose tolerance status and cognitive impairment in early middle-aged women
pp. 788-791(4)
Authors: Fuh, J-L.; Wang, S-J.; Hwu, C-M.; Lu, S-R.

Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction
pp. 792-795(4)
Authors: Stone, M. A.; Burden, A. C.; Burden, M.; Baker, R.; Khunti, K.

Living with Type 2 diabetes: a family perspective
pp. 796-801(6)
Authors: White, P.; Smith, S. M.; O'Dowd, T.

Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy
pp. 802-802(1)
Authors: Kelly, K. L.; Ellison, J. M.; Goldstein, E.; Nomura, D. M.; Price, D. A.

Inhibition of nitric oxide increases arterial stiffness in Type 2 diabetic patients
pp. 803-804(2)
Authors: Alem, M.; Cleland, S.; Nazir, F.; Small, M.; Walters, M.

Which should we ADOPT: sulphonylureas or glitazones?
pp. 804-804(1)
Authors: Koshiyama, H.; Inagaki, N.; Seino, Y.

Low prevalence of mitochondrial DNA 3243A>G point mutation in Caucasians with unexplained renal disease
pp. 804-806(3)
Authors: Singh, R.; Edghill, E.; Bingham, C.; Ellard, S.; Hattersley, A. T.; Harries, L. W.

Diary dates
pp. 807-807(1)